{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:16Z","timestamp":1787021056481,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"St. Vincent's university hospital Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiating combined pulmonary fibrosis with emphysema (CPFE) from pure emphysema can be challenging on high-resolution computed tomography (HRCT). This has antifibrotic therapy implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty patients with suspected CPFE underwent late gadolinium-enhanced (LGE) thoracic magnetic resonance imaging (LGE-MRI) and HRCT. Data from twelve healthy control subjects from a previous study who underwent thoracic LGE-MRI were included for comparison. Quantitative LGE signal intensity (SI) was retrospectively compared in regions of fibrosis and emphysema in CPFE patients to similar lung regions in controls. Qualitative comparisons for the presence\/extent of reticulation, honeycombing, and traction bronchiectasis between LGE-MRI and HRCT were assessed by two readers in consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were significant quantitative differences in fibrosis SI compared to emphysema SI in CPFE patients (25.8, IQR 18.4\u201331.0\n                      <jats:italic>versus<\/jats:italic>\n                      5.3, IQR 5.0\u20138.1,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Significant differences were found between LGE-MRI and HRCT in the extent of reticulation (12.5, IQR 5.0\u201320.0\n                      <jats:italic>versus<\/jats:italic>\n                      25.0, IQR 15.0\u201326.3,\n                      <jats:italic>p =<\/jats:italic>\n                      0.038) and honeycombing (5.0, IQR 0.0\u201310.0\n                      <jats:italic>versus<\/jats:italic>\n                      20.0, IQR 10.6\u201320.0,\n                      <jats:italic>p =<\/jats:italic>\n                      0.001) but not traction bronchiectasis (10.0, IQR 5\u201315\n                      <jats:italic>versus<\/jats:italic>\n                      15.0, IQR 5\u201315,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.878). Receiver operator curve analysis of fibrosis SI compared to similarly located regions in control subjects showed an area under the curve of 0.82 (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002). A SI cutoff of 19 yielded a sensitivity of 75% and specificity of 86% in differentiating fibrosis from similarly located regions in control subjects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LGE-MRI can differentiate CPFE from pure emphysema and may be a useful adjunct test to HRCT in patients with suspected CPFE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-020-00187-w","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T11:41:26Z","timestamp":1604403686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRI"],"prefix":"10.1186","volume":"4","author":[{"given":"Hannah","family":"Fleming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Haughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"MacDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard M.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhny","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"McKone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3476-8793","authenticated-orcid":false,"given":"Jonathan D.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"187_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1183\/09031936.05.00021005","volume":"26","author":"V Cottin","year":"2005","unstructured":"Cottin V, Nunes H, Brillet PY et al (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26:586\u2013593. \nhttps:\/\/doi.org\/10.1183\/09031936.05.00021005","journal-title":"Eur Respir J"},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748. \nhttps:\/\/doi.org\/10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"187_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/rct.0000000000000184","volume":"39","author":"S Matsuoka","year":"2015","unstructured":"Matsuoka S, Yamashiro T, Matsushita S et al (2015) Morphological disease progression of combined pulmonary fibrosis and emphysema: comparison with emphysema alone and pulmonary fibrosis alone. J Comput Assist Tomogr 39:153\u2013159. \nhttps:\/\/doi.org\/10.1097\/rct.0000000000000184","journal-title":"J Comput Assist Tomogr"},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12890-016-0300-7","volume":"16","author":"L Zhang","year":"2016","unstructured":"Zhang L, Zhang C, Dong F et al (2016) Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis. BMC Pulm Med 16:137. \nhttps:\/\/doi.org\/10.1186\/s12890-016-0300-7","journal-title":"BMC Pulm Med"},{"key":"187_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000363064","volume":"88","author":"U Oltmanns","year":"2014","unstructured":"Oltmanns U, Kahn N, Palmowski K et al (2014) Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases. Respiration 88:199\u2013207. \nhttps:\/\/doi.org\/10.1159\/000363064","journal-title":"Respiration"},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071\u20132082. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1402584","journal-title":"N Engl J Med"},{"key":"187_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12890-019-1030-4","volume":"20","author":"L Richeldi","year":"2020","unstructured":"Richeldi L, Kolb M, Jouneau S et al (2020) Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis. BMC Pulm Med 20:3. \nhttps:\/\/doi.org\/10.1186\/s12890-019-1030-4","journal-title":"BMC Pulm Med"},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1513\/AnnalsATS.201706-473CC","volume":"15","author":"EW Pepin","year":"2018","unstructured":"Pepin EW, Verma N, Mehta HJ, Mohammed TL (2018) Combined pulmonary fibrosis and emphysema. Ann Am Thorac Soc 15:110\u2013112. \nhttps:\/\/doi.org\/10.1513\/AnnalsATS.201706-473CC","journal-title":"Ann Am Thorac Soc"},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2214\/ajr.180.3.1800827","volume":"180","author":"M Koyama","year":"2003","unstructured":"Koyama M, Johkoh T, Honda O et al (2003) Chronic cystic lung disease: diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol 180:827\u2013835. \nhttps:\/\/doi.org\/10.2214\/ajr.180.3.1800827","journal-title":"AJR Am J Roentgenol"},{"key":"187_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.rmed.2018.12.003","volume":"146","author":"M Alsumrain","year":"2019","unstructured":"Alsumrain M, De Giacomi F, Nasim F et al (2019) Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: characterization of presenting lung fibrosis and implications for survival. Respir Med 146:106\u2013112. \nhttps:\/\/doi.org\/10.1016\/j.rmed.2018.12.003","journal-title":"Respir Med"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.rmed.2013.06.015","volume":"107","author":"Y Kitaguchi","year":"2013","unstructured":"Kitaguchi Y, Fujimoto K, Hayashi R, Hanaoka M, Honda T, Kubo K (2013) Annual changes in pulmonary function in combined pulmonary fibrosis and emphysema: over a 5-year follow-up. Respir Med 107:1986\u20131992. \nhttps:\/\/doi.org\/10.1016\/j.rmed.2013.06.015","journal-title":"Respir Med"},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","volume":"343","author":"RJ Kim","year":"2000","unstructured":"Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445\u20131453. \nhttps:\/\/doi.org\/10.1056\/NEJM200011163432003","journal-title":"N Engl J Med"},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1161\/01.cir.100.19.1992","volume":"100","author":"RJ Kim","year":"1999","unstructured":"Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992\u20132002. \nhttps:\/\/doi.org\/10.1161\/01.cir.100.19.1992","journal-title":"Circulation"},{"key":"187_CR14","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1161\/01.CIR.0000120294.67948.E3","volume":"109","author":"K Shan","year":"2004","unstructured":"Shan K, Constantine G, Sivananthan M, Flamm SD (2004) Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 109:1328\u20131334. \nhttps:\/\/doi.org\/10.1161\/01.CIR.0000120294.67948.E3","journal-title":"Circulation"},{"key":"187_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5152\/dir.2016.15331","volume":"23","author":"LP Lavelle","year":"2017","unstructured":"Lavelle LP, Brady D, McEvoy S et al (2017) Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT. Diagn Interv Radiol 23:106\u2013111. \nhttps:\/\/doi.org\/10.5152\/dir.2016.15331","journal-title":"Diagn Interv Radiol"},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00330-012-2683-z","volume":"23","author":"Z Wang","year":"2013","unstructured":"Wang Z, Gu S, Leader JK et al (2013) Optimal threshold in CT quantification of emphysema. Eur Radiol 23:975\u2013984. \nhttps:\/\/doi.org\/10.1007\/s00330-012-2683-z","journal-title":"Eur Radiol"},{"key":"187_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1148\/radiol.11102216","volume":"259","author":"R Goetti","year":"2011","unstructured":"Goetti R, Kozerke S, Donati OF et al (2011) Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging. Radiology 259:704\u2013711. \nhttps:\/\/doi.org\/10.1148\/radiol.11102216","journal-title":"Radiology"},{"key":"187_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1148\/radiology.218.1.r01ja50215","volume":"218","author":"OP Simonetti","year":"2001","unstructured":"Simonetti OP, Kim RJ, Fieno DS et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215\u2013223. \nhttps:\/\/doi.org\/10.1148\/radiology.218.1.r01ja50215","journal-title":"Radiology"},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1081\/jcmr-120022267","volume":"5","author":"RJ Kim","year":"2003","unstructured":"Kim RJ, Shah DJ, Judd RM (2003) How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 5:505\u2013514. \nhttps:\/\/doi.org\/10.1081\/jcmr-120022267","journal-title":"J Cardiovasc Magn Reson"},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/01.cir.0000036368.63317.1c","volume":"106","author":"H Mahrholdt","year":"2002","unstructured":"Mahrholdt H, Wagner A, Holly TA et al (2002) Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 106:2322\u20132327. \nhttps:\/\/doi.org\/10.1161\/01.cir.0000036368.63317.1c","journal-title":"Circulation"},{"key":"187_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1164\/rccm.201607-1385OC","volume":"195","author":"ML Salisbury","year":"2017","unstructured":"Salisbury ML, Lynch DA, van Beek EJ et al (2017) Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes. Am J Respir Crit Care Med 195:921\u2013929. \nhttps:\/\/doi.org\/10.1164\/rccm.201607-1385OC","journal-title":"Am J Respir Crit Care Med"},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697\u2013722. \nhttps:\/\/doi.org\/10.1148\/radiol.2462070712","journal-title":"Radiology"},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381:1718\u20131727. \nhttps:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jmri.20075","volume":"19","author":"LE Thomson","year":"2004","unstructured":"Thomson LE, Kim RJ, Judd RM (2004) Magnetic resonance imaging for the assessment of myocardial viability. J Magn Reson Imaging 19:771\u2013788. \nhttps:\/\/doi.org\/10.1002\/jmri.20075","journal-title":"J Magn Reson Imaging"},{"key":"187_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1148\/rg.335125722","volume":"33","author":"P Rajiah","year":"2013","unstructured":"Rajiah P, Desai MY, Kwon D, Flamm SD (2013) MR imaging of myocardial infarction. Radiographics 33:1383\u20131412. \nhttps:\/\/doi.org\/10.1148\/rg.335125722","journal-title":"Radiographics"},{"key":"187_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1053\/euhj.2001.3038","volume":"23","author":"H Mahrholdt","year":"2002","unstructured":"Mahrholdt H, Wagner A, Judd RM, Sechtem U (2002) Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 23:602\u2013619. \nhttps:\/\/doi.org\/10.1053\/euhj.2001.3038","journal-title":"Eur Heart J"},{"key":"187_CR27","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL et al (2018) Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198:e44\u2013e68. \nhttps:\/\/doi.org\/10.1164\/rccm.201807-1255ST","journal-title":"Am J Respir Crit Care Med"},{"key":"187_CR28","doi-asserted-by":"publisher","unstructured":"Lederer DJ, Martinez FJ (2018) Idiopathic pulmonary fibrosis. N Engl J Med 378:1811\u20131823. \nhttps:\/\/doi.org\/10.1056\/NEJMra1705751","DOI":"10.1056\/NEJMra1705751"},{"key":"187_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1164\/rccm.201803-0444PP","volume":"199","author":"X Wu","year":"2019","unstructured":"Wu X, Kim GH, Salisbury ML et al (2019) Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of quantitative analysis. Am J Respir Crit Care Med 199:12\u201321. \nhttps:\/\/doi.org\/10.1164\/rccm.201803-0444PP","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-020-00187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41747-020-00187-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-020-00187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T11:48:31Z","timestamp":1604404111000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-020-00187-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1186\/s41747-020-00187-w","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was approved by the Ethics Board of St. Vincent\u2019s University Hospital. Written informed consent was waived for this retrospective study. Note however that data from 12 healthy control subjects from a previous study (16) were included in the analysis for comparison. In that study, ethics approval was received and written informed consent was required and obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The project was approved by the Ethics Board of St. Vincent\u2019s University Hospital. Written informed consent was waived for this retrospective study. Images are entirely unidentifiable and there are no details on individuals reported within the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}